| Previous Section | Index | Home Page |
22 Jul 2004 : Column 620W—continued
Watermark Project
Mr. Oaten: To ask the Secretary of State for the Home Department whether his Department has joined the Watermark project. [182225]
Fiona Mactaggart: The Home Office joined the Watermark project in 2001.
HEALTH
Social Work Degree
Tim Loughton: To ask the Secretary of State for Health how many bursaries have been taken up by students studying for the new social work degree. [185525]
Dr. Ladyman: The total number of social work bursaries awarded by the General Social Care Council in the 2003–04 academic year was 7,626.
This represents students on the new degree and diploma in social work programmes. It is not possible to separately identify those on the new degree.
Alzheimer's Disease
Tim Loughton: To ask the Secretary of State for Health how many people (a) under the age of 40, (b) aged 40 to 50 and (c) aged 50 to 60 years are (i) diagnosed with Alzheimer's and (ii) receiving NHS treatment for Alzheimer's. [185414]
Dr. Ladyman: Although the Department does not routinely collect information on the number of people diagnosed with dementia, there are an estimated 750,000 people with dementia in the United Kingdom, of whom around 400,000 have Alzheimer's disease (around 55 per cent.). Around 18,000 of the total number of people with dementia are aged under 65 years.
Anaphylaxis
Mr. Chaytor: To ask the Secretary of State for Health how many people in England have died from anaphylaxis in each of the last five years; how many hospital doctors in England have received specialist training in the treatment of anaphylaxis; and what plans he has to fund further (a) research and (b) professional development in this field. [184431]
22 Jul 2004 : Column 621W
Dr. Ladyman: The table shows the number of deaths in England and Wales between 1998–2002 where one or more of the conditions mentioned on the death certificate was classified as anaphylactic shock by the International Classification of Diseases (ICD).
| Calendar year | Number of deaths |
|---|---|
| 1998 | 9 |
| 1999 | 12 |
| 2000 | 11 |
| 2001 | 3 |
| 2002 | 10 |
(75) Causes of death were classified as anaphylactic shock for the years 1998 to 2000 using the International Classification of Diseases, Ninth Revision (ICD-9) codes
995.0—Anaphylactic shock
999.4—Anaphylactic shock due to serum
and for the years 2001 and 2002 using the International Classification of Diseases, Tenth Revision (ICD-10) codes
T78.0—Anaphylactic shock due to adverse food reaction
T78.2—Anaphylactic shock, unspecified
T80.5—Anaphylactic shock due to serum
T88.6—Anaphylactic shock due to adverse effect of correct drug or medicament properly administered.
(76) Figures are based on deaths occurring in each calendar year
Source:
Office for National Statistics
Information is not available centrally on hospital doctors who have received specialist training in anaphylaxis. Post registration training needs for national health service staff are determined against local
22 Jul 2004 : Column 622W
NHS priorities, through appraisal processes and training needs analyses informed by Local Delivery Plans and the needs of the service.
The main agency through which the Government supports medical and clinical research is the Medical Research Council (MRC). The MRC is an independent body which receives its grant-in-aid from the Office of Science and Technology. The Medical Research Council does not currently fund any research directly on anaphylaxis. However, the Council does fund a considerable amount of basic underpinning research in immunology and allergy which may lead to further understanding of the mechanisms involved.
Antipsychotic Drugs
Sandra Gidley: To ask the Secretary of State for Health (1) how many prescription items were dispensed in the community in England for atypical antipsychotic drugs, in each of the last three years (a) broken down by health authority and (b) in total; and if he will make a statement; [184801]
Sandra Gidley: To ask the Secretary of State for Health (2) how many prescription items were dispensed in the community in England for all antipsychotic drugs, in each of the last three years (a) broken down by health authority and (b) in total; and if he will make a statement. [184802]
Ms Rosie Winterton: Information on the numbers of prescription items of atypical traditional and all antipsychotic drugs dispensed in the community in England in each of the last three years broken down by strategic health authority is shown in the table.
Notes:
1. PCA data covers all prescription items that are dispensed in the community in England, (this covers items dispensed by community pharmacists and appliance contractors, dispensing doctors, and prescriptions submitted by prescribing doctors for items personally administered PCA data does not include items dispensed in hospitals or private prescriptions.
2. Antipsychotics are defined in the British National Formulary (BNF) paragraph 4.2.1, antipsychotic drugs. Atypical antipsychotics cover the drugs Amisulpride, Clozapine, Oianzapine, Quetiapine, Risperidone, Sertindole and Zotepine contained within BNF 4.2.1. Antipsychotic depot injections (BNF 4.2.2) have been excluded from this analysis. the same as the StHA in which the drug was prescribed.
3. The information by Strategic Health Authority (StHA) is the StHA in which the drug was dispensed in the community. This is not necessarily
4. Doctors, dentists or nurses write prescriptions on a prescription form. Each single item written on the form is counted as a prescription item.
Source:
Prescription Cost Analysis (PCA) data from the Prescription Pricing Authority
22 Jul 2004 : Column 623W
| Next Section | Index | Home Page |